Media advisory - Resonant Medical Co. of Montreal is purchased by
Sweden-based global company Elekta for CAD $30 Million

MONTREAL, May 31 /CNW Telbec/ - Swedish company Elekta announced today the acquisition of Resonant Medical Inc. Based in Montreal, Resonant Medical specializes in image-guided radiation therapy for treating cancer, using the latest generation of 3D ultra sound technology. The technology, which has been developed in Montreal with leading academic institutions, improves treatment accuracy for prostate, breast, liver, uterus, bladder as well as head and neck cancers. Resonant Medical's equipment is used daily in cancer treatment centers in the U,S., Canada, Italy,The Netherlands, and Ireland.

Media representatives are invited to a press briefing at Medical Resonant's headquarters to learn more about this business transaction, witness a demonstration of the company's equipment and meet with the CEOs of Elekta and Resonant Medical.

NOTE: Elekta's news release has been broadcast over the international news wires earlier this afternoon. In Canada, the news release has been sent through Canada News Wire at 15:39 p.m.

    
    WHAT:     Press briefing announcing the purchase of Resonant Medical
    WHO:      Dr. Tony Falco, Chief Executive Officer, Resonant Medical
              Tomas Puusepp, President and CEO of Elekta
    WHEN:     Tuesday, June 1st, 2010, at 10:00 a.m.
    WHERE:    Resonant Medical, 2050, Bleury Street, Suite 200, Montreal
    

SOURCE RESONANT MEDICAL INC.

For further information: For further information: Jean-Pierre Trudel, Jean-Pierre Trudel & Associates, (514) 347-6111

Organization Profile

RESONANT MEDICAL INC.

More on this organization

ELEKTA, INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890